Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > TSX Down 4.26% on the week...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by health1234on Dec 13, 2015 11:27pm
82 Views
Post# 24381787

RE:RE:RE:RE:RE:RE:RE:RE:TSX Down 4.26% on the week...

RE:RE:RE:RE:RE:RE:RE:RE:TSX Down 4.26% on the week...
notwrong-  legitimate users, what is your point of view for CXR pls mention. From your last 15 posts you are  blaming accsing expressions are every where in your post,even you don't own a single stock.( you admit ) 
CHECK YOUR OWN POSTINGS.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities